{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:25:24Z","timestamp":1793172324359,"version":"4.5.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background and Aims<\/jats:title>\n            <jats:p>NASH is a common disease associated with increased rates of thromboembolism (TE). Although exercise training can lessen thrombotic risk in patients with vascular disease, whether similar findings are observed in patients with NASH is open for study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Approach and Results<\/jats:title>\n            <jats:p>We conducted a 20\u2010week randomized controlled clinical trial involving patients with biopsy\u2010confirmed NASH. Patients were randomly assigned (2:1 ratio) to receive either an exercise training program or standard clinical care. The primary endpoint was change in plasminogen activator inhibitor 1 (PAI\u20101) level, an established thrombotic biomarker. Twenty\u2010eight patients were randomly assigned (18 exercise training and 10 standard clinical care). PAI\u20101 level was significantly decreased by exercise training when compared to standard clinical care (\u221240\u00a0\u00b1\u00a0100 vs. +70\u00a0\u00b1\u00a063 ng\/ml; <jats:italic toggle=\"yes\">p<\/jats:italic>\u00a0=\u00a00.02). Exercise training decreased MRI proton density fat fraction (MRI\u2010PDFF; \u22124.7\u00a0\u00b1\u00a05.6 vs. 1.2\u00a0\u00b1\u00a02.8% absolute liver fat; <jats:italic toggle=\"yes\">p<\/jats:italic>\u00a0=\u00a00.01); 40% of exercise subjects had a \u226530% relative reduction in MRI\u2010PDFF (histological response threshold) compared to 13% for standard of care (<jats:italic toggle=\"yes\">p<\/jats:italic>\u00a0&lt;\u00a00.01). Exercise training improved fitness (VO<jats:sub>2<\/jats:sub> peak, +3.0\u00a0\u00b1\u00a05.6 vs. \u22121.8\u00a0\u00b1\u00a05.1 ml\/kg\/min; <jats:italic toggle=\"yes\">p<\/jats:italic>\u00a0=\u00a00.05) in comparison to standard clinical care.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This clinical trial showed that, independent of weight loss or dietary change, exercise training resulted in a significantly greater decrease in thrombotic risk than standard clinical care in patients with NASH, in parallel with MRI\u2010PDFF reduction and improvement in fitness. Future studies are required to determine whether exercise training can directly impact patient outcomes and lower rates of TE.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.32274","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T09:43:22Z","timestamp":1639129402000},"page":"172-185","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":65,"title":["NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH"],"prefix":"10.1097","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3352-6928","authenticated-orcid":false,"given":"Jonathan G.","family":"Stine","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Medicine,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"},{"name":"Department of Public Health Sciences,The Pennsylvania State University\u2013College of Medicine,Hershey,Pennsylvania,USA"},{"name":"Liver Center,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"},{"name":"Cancer Institute,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Schreibman","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Medicine,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"},{"name":"Liver Center,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison J.","family":"Faust","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Medicine,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"},{"name":"Liver Center,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Dahmus","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Medicine,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Stern","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Medicine,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Soriano","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Medicine,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9776-758X","authenticated-orcid":false,"given":"Gloriany","family":"Rivas","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Medicine,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6639-7931","authenticated-orcid":false,"given":"Breianna","family":"Hummer","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Medicine,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot R.","family":"Kimball","sequence":"additional","affiliation":[{"name":"Department of Physiology,The Pennsylvania State University\u2013College of Medicine,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0965-3123","authenticated-orcid":false,"given":"Nate R.","family":"Geyer","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences,The Pennsylvania State University\u2013College of Medicine,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernon M.","family":"Chinchilli","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences,The Pennsylvania State University\u2013College of Medicine,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4845-9991","authenticated-orcid":false,"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,Department of Medicine,University of California San Diego,San Diego,California,USA"},{"name":"NAFLD Research Center,University of California San Diego,San Diego,California,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences,The Pennsylvania State University\u2013College of Medicine,Hershey,Pennsylvania,USA"},{"name":"Cancer Institute,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"},{"name":"Department of Kinesiology,The Pennsylvania State University\u2013College of Medicine,Hershey,Pennsylvania,USA"},{"name":"Department of Physical Medicine and Rehabilitation,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sciamanna","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences,The Pennsylvania State University\u2013College of Medicine,Hershey,Pennsylvania,USA"},{"name":"Cancer Institute,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"},{"name":"Department of Medicine,The Pennsylvania State University\u2013Milton S. Hershey Medical Center,Hershey,Pennsylvania,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,22]]},"reference":[{"key":"hep32274-bib-0001-20250824","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non\u2010alcoholic fatty liver disease\u2014a global public health perspective","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"hep32274-bib-0002-20250824","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta\u2010analysis","volume":"65","year":"2017","journal-title":"Hepatology"},{"key":"hep32274-bib-0003-20250824","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"hep32274-bib-0004-20250824","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review","volume":"158","year":"2020","journal-title":"Gastroenterology"},{"key":"hep32274-bib-0005-20250824","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.14937","article-title":"Systematic review with meta\u2010analysis: risk of hepatocellular carcinoma in non\u2010alcoholic steatohepatitis without cirrhosis compared to other liver diseases","volume":"48","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"hep32274-bib-0006-20250824","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/apt.16583","article-title":"Systematic review with network meta\u2010analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH","volume":"54","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"hep32274-bib-0007-20250824","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11901-020-00543-9","article-title":"Exercise as medicine: the impact of exercise training on nonalcoholic fatty liver disease","volume":"19","year":"2020","journal-title":"Curr Hepatol Rep"},{"key":"hep32274-bib-0008-20250824","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","year":"2015","journal-title":"Gastroenterology"},{"key":"hep32274-bib-0009-20250824","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2174\/1381612826666200131101553","article-title":"Nonalcoholic fatty liver disease\u2010evidence for a thrombophilic state?","volume":"26","year":"2020","journal-title":"Curr Pharm Des"},{"key":"hep32274-bib-0010-20250824","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/lt.24134","article-title":"Increased risk of portal vein thrombosis in patients with cirrhosis due to non\u2010alcoholic steatohepatitis (NASH)","volume":"21","year":"2015","journal-title":"Liver Transpl"},{"key":"hep32274-bib-0011-20250824","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4254\/wjh.v9.i3.139","article-title":"Advanced non\u2010alcoholic steatohepatitis cirrhosis: a high\u2010risk population for pre\u2010liver transplant portal vein thrombosis","volume":"9","year":"2017","journal-title":"World J Hepatol"},{"key":"hep32274-bib-0012-20250824","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41424-018-0002-y","article-title":"Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non\u2010alcoholic steatohepatitis","volume":"9","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"hep32274-bib-0013-20250824","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1161\/STROKEAHA.111.622217","article-title":"Plasminogen activator inhibitor\u20101 and thrombotic cerebrovascular diseases","volume":"43","year":"2012","journal-title":"Stroke"},{"key":"hep32274-bib-0014-20250824","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/oby.2008.64","article-title":"NASH predicts plasma inflammatory biomarkers independently of visceral fat in men","volume":"16","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"hep32274-bib-0015-20250824","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1467-789X.2002.00056.x","article-title":"Obesity, haemostasis and the fibrinolytic system","volume":"3","year":"2002","journal-title":"Obes Rev"},{"key":"hep32274-bib-0016-20250824","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI\u20101","volume":"116","year":"2010","journal-title":"Blood"},{"key":"hep32274-bib-0017-20250824","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13018-018-0716-2","article-title":"Plasminogen activator inhibitor\u20101: a risk factor for deep vein thrombosis after total hip arthroplasty","volume":"13","year":"2018","journal-title":"J Orthop Surg Res"},{"key":"hep32274-bib-0018-20250824","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2165\/00007256-200333110-00002","article-title":"Exercise\u2010induced changes in coagulation and fibrinolysis in healthy populations and patients with cardiovascular disease","volume":"33","year":"2003","journal-title":"Sports Med"},{"key":"hep32274-bib-0019-20250824","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jvs.2004.07.030","article-title":"Exercise training enhances endogenous fibrinolysis in peripheral arterial disease","volume":"40","year":"2004","journal-title":"J Vasc Surg"},{"key":"hep32274-bib-0020-20250824","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00007256-200434030-00004","article-title":"Exercise and training effects on blood haemostasis in health and disease: an update","volume":"34","year":"2004","journal-title":"Sports Med"},{"key":"hep32274-bib-0021-20250824","doi-asserted-by":"crossref","first-page":"100560","DOI":"10.1016\/j.conctc.2020.100560","article-title":"Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH","volume":"18","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"key":"hep32274-bib-0022-20250824","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","year":"2005","journal-title":"Hepatology"},{"key":"hep32274-bib-0023-20250824","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata\u2010driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","journal-title":"J Biomed Inform"},{"key":"hep32274-bib-0024-20250824","article-title":"resting and exercise energy metabolism after liver transplantation for nonalcoholic steatohepatitis","volume":"3","year":"2017","journal-title":"Transplant Direct"},{"key":"hep32274-bib-0025-20250824","first-page":"1376","article-title":"Aerobic capacity and exercise performance in nonalcoholic fatty liver disease","volume":"59","year":"2019","journal-title":"J Sports Med Phys Fitness"},{"key":"hep32274-bib-0026-20250824","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/01.CIR.83.5.1692","article-title":"Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults","volume":"83","year":"1991","journal-title":"Circulation"},{"key":"hep32274-bib-0027-20250824","first-page":"1210","article-title":"Effects of exercise training on plasminogen activator inhibitor activity","volume":"24","year":"1992","journal-title":"Med Sci Sports Exerc"},{"key":"hep32274-bib-0028-20250824","article-title":"Control group design, contamination and drop\u2010out in exercise oncology trials: a systematic review","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"hep32274-bib-0029-20250824","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cgh.2016.07.031","article-title":"Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial","volume":"15","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32274-bib-0030-20250824","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/CS20150308","article-title":"Modified high\u2010intensity interval training reduces liver fat and improves cardiac function in non\u2010alcoholic fatty liver disease: a randomized controlled trial","volume":"129","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"hep32274-bib-0031-20250824","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/gut.2011.242073","article-title":"Resistance exercise reduces liver fat and its mediators in non\u2010alcoholic fatty liver disease independent of weight loss","volume":"60","year":"2011","journal-title":"Gut"},{"key":"hep32274-bib-0032-20250824","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1210\/jc.2016-2353","article-title":"Exercise training reduces liver fat and increases rates of VLDL clearance but not VLDL production in NAFLD","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"hep32274-bib-0033-20250824","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.3748\/wjg.v20.i15.4382","article-title":"Effect of resistance training on non\u2010alcoholic fatty\u2010liver disease: a randomized\u2010clinical trial","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"hep32274-bib-0035-20250824","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.cgh.2020.08.061","article-title":"Change in MRI\u2010PDFF and histologic response in patients with nonalcoholic steatohepatitis: a systematic review and meta\u2010analysis","volume":"19","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32274-bib-0036-20250824","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00005768-200105000-00012","article-title":"Physical fitness and activity as separate heart disease risk factors: a meta\u2010analysis","volume":"33","year":"2001","journal-title":"Med Sci Sports Exerc"},{"key":"hep32274-bib-0037-20250824","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.31121","article-title":"Multicenter validation of association between decline in MRI\u2010PDFF and histologic response in NASH","volume":"72","year":"2020","journal-title":"Hepatology"},{"key":"hep32274-bib-0038-20250824","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.31205","article-title":"Cilofexor, a nonsteroidal FXR agonist, in non\u2010cirrhotic patients with nonalcoholic steatohepatitis: a phase 2 randomized controlled trial","volume":"72","year":"2020","journal-title":"Hepatology"},{"key":"hep32274-bib-0039-20250824","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL\u20103196) for the treatment of non\u2010alcoholic steatohepatitis: a multicentre, randomised, double\u2010blind, placebo\u2010controlled, phase 2 trial","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"hep32274-bib-0040-20250824","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL\u2010EASD\u2010EASO Clinical Practice Guidelines for the management of non\u2010alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"hep32274-bib-0041-20250824","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12876-020-01204-3","article-title":"Physical activity intervention for non\u2010diabetic patients with non\u2010alcoholic fatty liver disease: a meta\u2010analysis of randomized controlled trials","volume":"20","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"hep32274-bib-0042-20250824","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/obr.12719","article-title":"The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta\u2010analysis","volume":"19","year":"2018","journal-title":"Obes Rev"},{"key":"hep32274-bib-0043-20250824","doi-asserted-by":"crossref","first-page":"H1298","DOI":"10.1152\/ajpheart.00306.2014","article-title":"Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease","volume":"307","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"hep32274-bib-0044-20250824","article-title":"Cirrhosis is associated with an increased 30\u2010day mortality after venous thromboembolism","volume":"6","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"hep32274-bib-0045-20250824","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/01.CIR.98.21.2241","article-title":"High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor","volume":"98","year":"1998","journal-title":"Circulation"},{"key":"hep32274-bib-0046-20250824","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/apt.15989","article-title":"Improvement in histological endpoints of MAFLD following a 12\u2010week aerobic exercise intervention","volume":"52","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"hep32274-bib-0047-20250824","doi-asserted-by":"crossref","first-page":"43029","DOI":"10.1038\/srep43029","article-title":"High\u2010intensity aerobic exercise improves both hepatic fat content and stiffness in sedentary obese men with nonalcoholic fatty liver disease","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"hep32274-bib-0048-20250824","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: a key mediator of steatohepatitis in metabolic liver disease","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"hep32274-bib-0049-20250824","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2337\/diab.46.5.860","article-title":"Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease","volume":"46","year":"1997","journal-title":"Diabetes"},{"key":"hep32274-bib-0050-20250824","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.31806","article-title":"Glycemic control predicts severity of hepatocyte ballooning and hepatic fibrosis in nonalcoholic fatty liver disease","volume":"74","year":"2021","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.32274","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.32274","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T23:02:13Z","timestamp":1756076533000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,22]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.32274","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,22]]},"assertion":[{"value":"2021-09-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}